相关实验视频

Updated: Jun 21, 2025

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

通过增强的分子动力学模拟揭示了对P-糖蛋白连接体运输和抑制的机械洞察力

Ahmad Elbahnsi¹, Balint Dudas¹, Salvatore Cisternino²

¹Université Paris Cité, CNRS UMR 8038 CiTCoM, Inserm U1268 MCTR, Paris, France.

Computational and structural biotechnology journal

|July 11, 2024

概括

P-glycoprotein (P-gp) 在状态之间过渡到运输基板. 曲的TM4/TM10螺旋是向外运输的关键,而在封闭状态下曲的螺旋会影响NBD2通信,影响流出功能.

科学领域:

生物化学生物化学
分子生物学分子生物学
结构生物学结构生物学

背景情况:

P-glycoprotein (P-gp) 对于细胞排毒和药物排放至关重要.
P-gp的形状变化 (面向内,封闭,面向外) 对于基质运输至关重要.
在癌症治疗中,P-gp调解多药耐药性 (MDR).

研究的目的:

阐明P-gp形态状态的结构和功能动态.
研究P-gp状态转换和基质转移的基础机制.
确定参与P-gp抑制的关键结构元素和接口.

主要方法:

经典和增强的分子动力学 (MD) 模拟.
动力激发的目标MD (ketMD) 和亚亚巴特偏差MD (ABMD).
对跨膜螺旋 (TM) 和核酸结合域 (NBD) 相互作用的分析.

主要成果:

TM4和TM10螺旋的解对于面向外的形状是必不可少的.
在封闭状态下曲的TM4/TM10螺旋改变了TMD-NBD2通信,可能会抑制流量.
NBD1-TMD2链接器通过TM4-TM6门户促进胆固醇的进入,这表明基质/抑制剂结合机制.

结论:

P-gp形态动力学是由特定的螺旋运动和域相互作用来调节的.
链接区域及其与胆固醇的相互作用可能是P-gp抑制剂的新目标.
了解这些机制可以为制定克服癌症中MDR的策略提供信息.

关键词:

美国ABC运输商ABC运输商在ABCB1中,ABCB1是ABCB1.增强的分子动力学.这是一种P-glycoprotein蛋白.转移机制的转移机制

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Carrier-Mediated Transport

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Nonlinear Pharmacokinetics: Role of Transporters

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...